Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo‐controlled randomized...

por Schim, Jack D., Anderson, Carlton, Brunner, Elizabeth, Hirman, Joe, Ogbru, Annette, Cady, Roger, McGill, Lora
Publicado 2022

Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review

por Blumenfeld, Andrew M., Frishberg, Benjamin M., Schim, Jack D., Iannone, Ashley, Schneider, Gary, Yedigarova, Larisa, Manack Adams, Aubrey
Publicado 2021